ALT – Altimmune Inc
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
24.92
Margin Of Safety %
Put/Call OI Ratio
0.12
EPS Next Q Diff
-0.93
EPS Last/This Y
0.36
EPS This/Next Y
-0.34
Price
5.39
Target Price
20.14
Analyst Recom
1.67
Performance Q
33.17
Relative Volume
1.92
Beta
0.06
Ticker: ALT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | ALT | 3.87 | 0.32 | 0.59 | 229130 |
| 2025-12-29 | ALT | 3.71 | 0.31 | 0.16 | 217596 |
| 2025-12-30 | ALT | 3.6 | 0.30 | 0.11 | 220216 |
| 2025-12-31 | ALT | 3.61 | 0.28 | 0.10 | 227012 |
| 2026-01-02 | ALT | 3.52 | 0.27 | 0.08 | 229554 |
| 2026-01-05 | ALT | 4.09 | 0.23 | 0.09 | 219046 |
| 2026-01-06 | ALT | 3.95 | 0.22 | 0.12 | 226985 |
| 2026-01-07 | ALT | 4.17 | 0.22 | 0.12 | 230207 |
| 2026-01-08 | ALT | 4.09 | 0.22 | 0.13 | 233147 |
| 2026-01-09 | ALT | 4.01 | 0.22 | 0.17 | 235295 |
| 2026-01-12 | ALT | 4.05 | 0.22 | 0.16 | 232217 |
| 2026-01-13 | ALT | 4.01 | 0.22 | 0.17 | 234139 |
| 2026-01-14 | ALT | 4.18 | 0.22 | 0.14 | 234865 |
| 2026-01-15 | ALT | 4.22 | 0.22 | 0.04 | 236466 |
| 2026-01-16 | ALT | 4.24 | 0.20 | 0.06 | 247110 |
| 2026-01-20 | ALT | 4.22 | 0.11 | 0.14 | 115330 |
| 2026-01-21 | ALT | 4.61 | 0.12 | 0.11 | 118551 |
| 2026-01-22 | ALT | 5.39 | 0.12 | 0.17 | 123356 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | ALT | 3.87 | 26.4 | -78.3 | -0.98 |
| 2025-12-29 | ALT | 3.68 | 26.4 | -71.5 | -0.98 |
| 2025-12-30 | ALT | 3.60 | 26.4 | -79.1 | -0.98 |
| 2025-12-31 | ALT | 3.61 | 26.4 | -86.4 | -0.98 |
| 2026-01-02 | ALT | 3.51 | 26.4 | -77.2 | -0.98 |
| 2026-01-05 | ALT | 4.09 | 26.4 | -147.6 | -0.98 |
| 2026-01-06 | ALT | 3.95 | 26.4 | -76.1 | -0.98 |
| 2026-01-07 | ALT | 4.18 | 26.4 | -106.6 | -0.98 |
| 2026-01-08 | ALT | 4.09 | 26.4 | -79.9 | -0.98 |
| 2026-01-09 | ALT | 4.02 | 26.4 | -82.3 | -0.98 |
| 2026-01-12 | ALT | 4.05 | 26.4 | -89.1 | -0.98 |
| 2026-01-13 | ALT | 4.01 | 26.4 | -83.8 | -0.98 |
| 2026-01-14 | ALT | 4.18 | 26.4 | -100.6 | -0.98 |
| 2026-01-15 | ALT | 4.22 | 26.4 | -90.2 | -0.98 |
| 2026-01-16 | ALT | 4.24 | 26.4 | -87.8 | -0.98 |
| 2026-01-20 | ALT | 4.23 | 26.4 | -86.4 | -0.98 |
| 2026-01-21 | ALT | 4.61 | 26.4 | -114.6 | -0.98 |
| 2026-01-22 | ALT | 5.39 | 26.4 | -135.0 | -0.98 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | ALT | 3.65 | 3.96 | 22.89 |
| 2025-12-29 | ALT | 3.65 | 3.95 | 22.89 |
| 2025-12-30 | ALT | 3.57 | 3.95 | 22.89 |
| 2025-12-31 | ALT | 3.57 | 3.95 | 22.89 |
| 2026-01-02 | ALT | 3.57 | 3.95 | 22.89 |
| 2026-01-05 | ALT | 3.64 | 3.96 | 22.89 |
| 2026-01-06 | ALT | 3.64 | 3.96 | 22.89 |
| 2026-01-07 | ALT | 3.64 | 3.96 | 22.89 |
| 2026-01-08 | ALT | 3.64 | 3.96 | 22.89 |
| 2026-01-09 | ALT | 4.37 | 3.96 | 22.89 |
| 2026-01-12 | ALT | 4.30 | 3.96 | 22.89 |
| 2026-01-13 | ALT | 4.37 | 3.96 | 24.91 |
| 2026-01-14 | ALT | 4.37 | 3.96 | 24.91 |
| 2026-01-15 | ALT | 4.37 | 3.96 | 24.92 |
| 2026-01-16 | ALT | 4.31 | 3.96 | 24.92 |
| 2026-01-20 | ALT | 4.31 | 3.90 | 24.92 |
| 2026-01-21 | ALT | 4.31 | 3.90 | 24.92 |
| 2026-01-22 | ALT | 4.31 | 3.90 | 24.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT
589 360 ]
Last Quarter Act. EPS
0.67
Avg. EPS Est. Current Quarter
-0.24
Avg. EPS Est. Next Quarter
-0.26
Insider Transactions
4.31
Institutional Transactions
3.9
Beta
0.06
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
24
Growth Score
22
Sentiment Score
56
Actual DrawDown %
78.1
Max Drawdown 5-Year %
-91.2
Target Price
20.14
P/E
Forward P/E
PEG
P/S
28068.21
P/B
2.77
P/Free Cash Flow
EPS
-1.07
Average EPS Est. Cur. Y
-0.98
EPS Next Y. (Est.)
-1.32
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-419575
Relative Volume
1.92
Return on Equity vs Sector %
-72.5
Return on Equity vs Industry %
-56.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
-135
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT
589 450 ]
Altimmune, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT
premarket after hours
ticker ALT
fair value insiders trading